Christina Lamers

MedicineBiochemistry, Genetics and Molecular BiologyImmunology and Microbiology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 3 papers. Top paper: “Compstatins: the dawn of clinical C3-targeted complement inhibition”.

Compstatins: the dawn of clinical C3-targeted complement inhibition

Trends in Pharmacological Sciences(2022)10.1016/j.tips.2022.01.004

N/A

0DataRank · unranked

71 citations

Dimitrios C. Mastellos, Daniel Ricklin, John D. Lambris, Christina Lamers

Insight into mode-of-action and structural determinants of the compstatin family of clinical complement inhibitors

Nature Communications(2022)10.1038/s41467-022-33003-7

N/A

0DataRank · unranked

38 citations

Xiaoguang Xue, Martin Smieško, Henri van Son, Bea Wagner, Nadja Berger +5 more

Complement-regulatory biomaterial coatings: Activity and selectivity profile of the factor H-binding peptide 5C6

Acta Biomaterialia(2022)10.1016/j.actbio.2022.10.055

N/A

0DataRank · unranked

14 citations

Sophia Koutsogiannaki, Ekaterina S. Umnyakova, Amal Hamid, Avneesh Gautam, Yiannis Sarigiannis +7 more